JP5401446B2 - 凍結貯蔵を目的とした、組み換えタンパク質溶液の安定化 - Google Patents
凍結貯蔵を目的とした、組み換えタンパク質溶液の安定化 Download PDFInfo
- Publication number
- JP5401446B2 JP5401446B2 JP2010506432A JP2010506432A JP5401446B2 JP 5401446 B2 JP5401446 B2 JP 5401446B2 JP 2010506432 A JP2010506432 A JP 2010506432A JP 2010506432 A JP2010506432 A JP 2010506432A JP 5401446 B2 JP5401446 B2 JP 5401446B2
- Authority
- JP
- Japan
- Prior art keywords
- solution
- recombinant protein
- recombinant
- nacl
- factor viii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明は、組み換えタンパク質の溶液、好ましくはバルク溶液の凍結及び貯蔵に関する。
NaCl及び/又はKClなどの一価塩の濃度が100mM以上である、組み換えタンパク質溶液を準備し、
上記溶液のガラス転移温度が凍結時に−56℃以上となるのに十分な量の炭水化物を上記溶液に添加し、
貯蔵するために、上記溶液を凍結する
ことを含む方法である。
凍結貯蔵を目的として安定化されており、
当該溶液のガラス転移温度が凍結時に−56℃以上となるのに十分な量の炭水化物を含有する
組み換えタンパク質溶液を提供する。
である。上記一価塩は、精製カラムから組み換えタンパク質を溶出するのに一般的に用いられるNaClであるのが好ましい。しかしながら、当該NaClの全て又は一部をKClで置き換えてもよい。また、バルク溶液は、例えば塩化カルシウムといった二価塩など、他の塩をさまざまな量で含有していてもよい。
えば糖類、二糖類、オリゴ糖類、及び多糖類などである。例として、デキストラン、サイクロデキストラン、キトサン、デンプン、ヒアルロン酸、セルロース、ラフィノース、マルトース、ラクトース、スタキオース、及び、それらの組み合わせなどが挙げられる。好ましい例は、注射用として承認済みの炭水化物であり、例えばショ糖、トレハロース、ヒドロキシエチルデンプン、デキストラン、又は、それらの組み合わせなどが挙げられる。医薬品グレードの炭水化物は、多くの供給業者から市販されている。
Claims (18)
- 凍結貯蔵のために、組み換えタンパク質溶液を安定化する方法であって、
a.NaCl及び/又はKClの濃度が100mM以上である、組み換えタンパク質溶液を準備し、
b.前記溶液のガラス転移温度が凍結時に−56℃以上となるのに十分な、前記溶液の重量に基づいて8〜25重量%の量の炭水化物を前記溶液に添加し、
c.貯蔵するために、前記溶液を凍結する
ことを含む方法。 - 前記組み換えタンパク質溶液はバルク溶液である、請求項1に記載の方法。
- 前記溶液のNaCl濃度は100mM以上である、請求項1に記載の方法。
- 前記炭水化物は、ショ糖、トレハロース、ヒドロキシエチルデンプン、デキストラン、及び、それらの組み合わせからなる群から選択される、請求項1に記載の方法。
- 前記バルク溶液のNaCl濃度は300mM以上である、請求項1に記載の方法。
- 前記バルク溶液のNaCl濃度は600mM以上である、請求項1に記載の方法。
- 前記組み換えタンパク質は第VIII因子である、請求項1に記載の方法。
- 前記ガラス転移温度は、−56℃〜−35℃である、請求項1に記載の方法。
- アミノ酸及び/又は界面活性剤を添加することをさらに含む、請求項1に記載の方法。
- 組み換えタンパク質溶液であって、
凍結貯蔵を目的として安定化されており、
NaCl及び/又はKClの濃度が100mM以上であり、
当該溶液のガラス転移温度が凍結時に−56℃以上となるのに十分な、前記溶液の重量に基づいて8〜25重量%の量の炭水化物を含有する
組み換えタンパク質溶液。 - バルク溶液を含む、請求項10に記載の組み換えタンパク質溶液。
- NaCl濃度は100mM以上である、請求項10に記載の溶液。
- 前記炭水化物は、ショ糖、トレハロース、ヒドロキシエチルデンプン、デキストラン、及び、それらの組み合わせからなる群から選択される、請求項10に記載の組み換えタンパク質溶液。
- 前記溶液のNaCl濃度は300mM以上である、請求項10に記載の組み換えタンパク質溶液。
- 前記溶液のNaCl濃度は600mM以上である、請求項10に記載の組み換えタンパク質溶液。
- 前記組み換えタンパク質は第VIII因子である、請求項10に記載の組み換えタンパク質溶液。
- 前記ガラス転移温度は、−56℃〜−35℃である、請求項10に記載の組み換えタンパク質溶液。
- NaCl濃度が100mM以上であり、
組み換え第VIII因子濃度が0.0001マイクロモル〜10マイクロモルであり、
凍結貯蔵を目的として、ガラス転移温度が凍結時に−56℃以上となるのに十分な、溶液の重量に基づいて8〜25重量%の量の炭水化物の添加により安定化されている
組み換え第VIII因子溶液。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92669807P | 2007-04-26 | 2007-04-26 | |
US60/926,698 | 2007-04-26 | ||
PCT/US2008/061147 WO2008134310A1 (en) | 2007-04-26 | 2008-04-22 | Stabilization of liquid solutions of recombinant protein for frozen storage |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010525071A JP2010525071A (ja) | 2010-07-22 |
JP5401446B2 true JP5401446B2 (ja) | 2014-01-29 |
Family
ID=39926041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010506432A Expired - Fee Related JP5401446B2 (ja) | 2007-04-26 | 2008-04-22 | 凍結貯蔵を目的とした、組み換えタンパク質溶液の安定化 |
Country Status (15)
Country | Link |
---|---|
US (2) | US8187799B2 (ja) |
EP (1) | EP2150264A4 (ja) |
JP (1) | JP5401446B2 (ja) |
KR (2) | KR20150103333A (ja) |
CN (2) | CN101678066B (ja) |
AU (1) | AU2008245821B2 (ja) |
BR (1) | BRPI0810500A2 (ja) |
CA (1) | CA2683317C (ja) |
EC (1) | ECSP099704A (ja) |
HK (1) | HK1198815A1 (ja) |
IL (1) | IL201508A0 (ja) |
MX (1) | MX2009011367A (ja) |
RU (1) | RU2469739C2 (ja) |
WO (1) | WO2008134310A1 (ja) |
ZA (1) | ZA200907247B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10500771B2 (en) | 2014-06-13 | 2019-12-10 | Toppan Printing Co., Ltd. | Needle shaped body and method for manufacturing needle shaped body |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
CN105816858A (zh) * | 2007-12-28 | 2016-08-03 | 巴克斯特国际公司 | 重组vwf配方 |
US11197916B2 (en) | 2007-12-28 | 2021-12-14 | Takeda Pharmaceutical Company Limited | Lyophilized recombinant VWF formulations |
CN102387784B (zh) * | 2008-10-21 | 2014-04-02 | 巴克斯特国际公司 | 冻干的重组vwf配方 |
EP2427211A4 (en) * | 2009-05-04 | 2013-05-01 | Abbott Biotech Ltd | STABLE FORMULATIONS WITH HIGH PROTEIN CONCENTRATION OF ANTI-TNF-ALPHA HUMAN ANTIBODIES |
MX344727B (es) | 2010-11-11 | 2017-01-05 | Abbvie Biotechnology Ltd | Formulaciones liquidas de anticuerpos anti-tnf-alfa de alta concentracion mejoradas. |
JP6778111B2 (ja) | 2014-01-20 | 2020-10-28 | オクタファルマ・アーゲー | FVIII:C/FVIII:Agの改良された比を有する第VIII因子を製造するための方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4457916A (en) * | 1982-08-31 | 1984-07-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same |
JPS59134730A (ja) | 1983-01-20 | 1984-08-02 | Green Cross Corp:The | 血液凝固第8因子の加熱処理法 |
US5576194A (en) | 1986-07-11 | 1996-11-19 | Bayer Corporation | Recombinant protein production |
US5605884A (en) * | 1987-10-29 | 1997-02-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Factor VIII formulations in high ionic strength media |
CA1329760C (en) * | 1987-10-29 | 1994-05-24 | Ted C. K. Lee | Plasma and recombinant protein formulations in high ionic strength media |
US4877608A (en) * | 1987-11-09 | 1989-10-31 | Rorer Pharmaceutical Corporation | Pharmaceutical plasma protein formulations in low ionic strength media |
DE4111393A1 (de) * | 1991-04-09 | 1992-10-15 | Behringwerke Ag | Stabilisierte faktor viii-praeparationen |
US5278289A (en) * | 1991-11-12 | 1994-01-11 | Johnson Alan J | Antihemophilic factor stabilization |
EP1016673B1 (en) * | 1992-10-02 | 2006-02-01 | Genetics Institute, LLC | Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
US5576291A (en) * | 1993-09-13 | 1996-11-19 | Baxter International Inc. | Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency |
IL113010A0 (en) * | 1994-03-31 | 1995-10-31 | Pharmacia Ab | Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration |
US6818439B1 (en) * | 1994-12-30 | 2004-11-16 | Chiron Corporation | Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders |
US6790439B1 (en) * | 1995-06-07 | 2004-09-14 | Zymogenetics, Inc. | Thrombopoietin compositions |
SE9503380D0 (sv) * | 1995-09-29 | 1995-09-29 | Pharmacia Ab | Protein derivatives |
US5770700A (en) | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
US5763401A (en) * | 1996-07-12 | 1998-06-09 | Bayer Corporation | Stabilized albumin-free recombinant factor VIII preparation having a low sugar content |
US5804420A (en) | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
AT407255B (de) * | 1997-06-20 | 2001-02-26 | Immuno Ag | Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons |
CA2362927C (en) | 1999-02-22 | 2011-07-12 | University Of Connecticut | Novel albumin-free factor viii formulations |
EP1368486A4 (en) * | 1999-07-15 | 2009-04-01 | Genetics Inst Llc | IL-11 FORMULATIONS |
US7147876B2 (en) | 2001-08-13 | 2006-12-12 | Michael Hargreaves Riley | Compositions for removal of toxins |
DE10149030A1 (de) * | 2001-10-05 | 2003-04-10 | Viscum Ag | Stabile galenische gefriergetrocknete Arzneimittelzubereitung von rViscumin |
CA2490342C (en) * | 2002-06-21 | 2015-06-16 | Novo Nordisk A/S | Stabilised solid compositions of factor vii polypeptides |
KR100560697B1 (ko) | 2003-08-06 | 2006-03-16 | 씨제이 주식회사 | 알부민을 함유하지 않는 에리스로포이에틴 제제 |
-
2008
- 2008-04-22 KR KR1020157023163A patent/KR20150103333A/ko not_active Application Discontinuation
- 2008-04-22 US US12/597,333 patent/US8187799B2/en active Active
- 2008-04-22 RU RU2009143493/15A patent/RU2469739C2/ru not_active IP Right Cessation
- 2008-04-22 WO PCT/US2008/061147 patent/WO2008134310A1/en active Application Filing
- 2008-04-22 CA CA2683317A patent/CA2683317C/en not_active Expired - Fee Related
- 2008-04-22 BR BRPI0810500-6A2A patent/BRPI0810500A2/pt not_active IP Right Cessation
- 2008-04-22 AU AU2008245821A patent/AU2008245821B2/en not_active Ceased
- 2008-04-22 JP JP2010506432A patent/JP5401446B2/ja not_active Expired - Fee Related
- 2008-04-22 CN CN200880013538.9A patent/CN101678066B/zh not_active Expired - Fee Related
- 2008-04-22 CN CN201410074690.5A patent/CN103990116A/zh active Pending
- 2008-04-22 EP EP08746549.8A patent/EP2150264A4/en not_active Withdrawn
- 2008-04-22 MX MX2009011367A patent/MX2009011367A/es not_active Application Discontinuation
- 2008-04-22 KR KR1020097024549A patent/KR101578561B1/ko active IP Right Grant
-
2009
- 2009-10-14 IL IL201508A patent/IL201508A0/en unknown
- 2009-10-15 ZA ZA200907247A patent/ZA200907247B/xx unknown
- 2009-10-23 EC EC2009009704A patent/ECSP099704A/es unknown
-
2012
- 2012-04-30 US US13/459,806 patent/US8536125B2/en active Active
-
2014
- 2014-12-09 HK HK14112345.1A patent/HK1198815A1/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10500771B2 (en) | 2014-06-13 | 2019-12-10 | Toppan Printing Co., Ltd. | Needle shaped body and method for manufacturing needle shaped body |
Also Published As
Publication number | Publication date |
---|---|
CN101678066B (zh) | 2014-09-24 |
AU2008245821A1 (en) | 2008-11-06 |
IL201508A0 (en) | 2010-05-31 |
CN101678066A (zh) | 2010-03-24 |
HK1198815A1 (en) | 2015-06-12 |
BRPI0810500A2 (pt) | 2014-10-14 |
MX2009011367A (es) | 2010-03-22 |
CA2683317A1 (en) | 2008-11-06 |
KR20100017354A (ko) | 2010-02-16 |
US20120211698A1 (en) | 2012-08-23 |
US20100113744A1 (en) | 2010-05-06 |
KR20150103333A (ko) | 2015-09-09 |
EP2150264A4 (en) | 2014-09-24 |
US8187799B2 (en) | 2012-05-29 |
CN103990116A (zh) | 2014-08-20 |
WO2008134310A1 (en) | 2008-11-06 |
AU2008245821B2 (en) | 2013-07-04 |
WO2008134310A8 (en) | 2009-12-10 |
JP2010525071A (ja) | 2010-07-22 |
EP2150264A1 (en) | 2010-02-10 |
US8536125B2 (en) | 2013-09-17 |
KR101578561B1 (ko) | 2015-12-17 |
ZA200907247B (en) | 2010-08-25 |
RU2469739C2 (ru) | 2012-12-20 |
CA2683317C (en) | 2014-12-16 |
RU2009143493A (ru) | 2011-06-10 |
ECSP099704A (es) | 2009-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5401446B2 (ja) | 凍結貯蔵を目的とした、組み換えタンパク質溶液の安定化 | |
AU718901B2 (en) | Stabilized albumin-free recombinant factor VIII preparation having a low sugar content | |
TWI508735B (zh) | 凍乾的重組vwf調配物 | |
ES2208736T3 (es) | Formulacion proteinica que comprende factor viii o factor ix de coagulacion en una solucion acuosa. | |
US7381796B2 (en) | Dried blood factor composition comprising trehalose | |
EP1308170B1 (en) | Dried blood factor composition comprising trehalose | |
NO330048B1 (no) | Stabile faktor VIII-sammensetninger | |
US9682149B2 (en) | Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase | |
JP2010529997A5 (ja) | ||
AU2013204652B2 (en) | Stabilization of liquid solutions of recombinant protein for frozen storage | |
WO1999010011A1 (en) | Dried biologically or therapeutically active preparations | |
NO166727B (no) | Fremgangsmaate for fremstilling av rekombinant alfa-interferon | |
JP4880997B2 (ja) | Adamts13の安定化方法 | |
AU738891B2 (en) | Stable transglutaminase preparations and process for producing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20100709 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100709 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121120 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130219 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130226 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130321 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130328 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130419 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130426 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130911 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131008 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131028 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5401446 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |